Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Next Generation Access Platform

K-Number: K242376 · 2024-12-30

ApplicantBalt USA, LLC
Decision Date2024-12-30
Product CodeQJP
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Next Generation Access Platform is a medical device manufactured by Balt USA, LLC. It received FDA 510(k) clearance on 2024-12-30 under approval number K242376. The device is classified under product code QJP. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Next Generation Access Platform?

Next Generation Access Platform is a medical device that received FDA 510(k) clearance on 2024-12-30. It is manufactured by Balt USA, LLC. The 510(k) number is K242376.

When was Next Generation Access Platform approved by the FDA?

Next Generation Access Platform received FDA 510(k) clearance on 2024-12-30, under approval number K242376.

What company makes Next Generation Access Platform?

Next Generation Access Platform is manufactured by Balt USA, LLC.

What is the FDA product code for Next Generation Access Platform?

The FDA product code for Next Generation Access Platform is QJP.

Related Clinical Trials

Related PubMed Literature

Other Devices by Balt USA, LLC

View all 19 devices →

Related Devices (Code: QJP)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.